Member of the Board since 2022.
Gisela Sitbon holds a PhD in Molecular- and Microbiology from Karolinska Institute. She has a solid experience within the life-science industry ranging entrepreneurship, quality management, business development and venture capital.
Holdings in the company: 0 shares and 86,999 employee warrants
Independence: Gisela is independent in relation to the company and is independent in relation to the Company’s largest shareholders Text
Other Board assignments: Chairman of the board of Nanologica AB, Amplicon AB, Emplipharm AB and Gradientech AB. Board member of Sitbon Bioscience Partner Zenz AB.